Streetbeat News

CMRA

Comera Life Sciences Holdings Inc

Industry

Research and Development in Biotechnology

Open

0.00

Mkt cap

3.1K

Volume

12K

High

0.00

P/E Ratio

N/A

52-wk high

0.09

Low

0.00

Div yield

N/A

52-wk low

0.00

In Friday's after-market session, several healthcare stocks experienced significant movements. Comera Life Sciences (CMRA), SenesTech (SNES), Aravive (ARAV), China SXT Pharmaceuticals (SXTC), Co-Diagnostics (CODX), and Oncternal Therapeutics (ONCT) saw gains following their Q3 earnings reports. Conversely, XTL Biopharmaceuticals (XTLB), NeuroMetrix (NURO), TRACON Pharma (TCON), Jaguar Health (JAGX), Intelligent Bio Solutions (INBS), and Sunshine Biopharma (SBFM) experienced declines. The movements were attributed to recent earnings reports and trading volumes.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 9:31 pm

Comera Life Sciences (NASDAQ:CMRA) reported Q3 losses of $(0.10) per share, a 50% improvement from $(0.20) per share YoY. However, sales decreased by 41.98% to $136.31K from $234.92K YoY.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:19 pm

During Tuesday's intraday session, several healthcare stocks experienced significant movements. LianBio, TransCode Therapeutics, ImmunityBio, Ambrx Biopharma, Universe Pharmaceuticals, and Comera Life Sciences saw their shares increase by 128.1%, 45.24%, 27.92%, 25.47%, 24.05%, and 20.08% respectively. On the other hand, LumiraDx, INVO Bioscience, Sonoma Pharmaceuticals, Avenue Therapeutics, Brainstorm Cell, and Tempest Therapeutics saw their shares decline by 43.5%, 34.91%, 18.63%, 16.51%, 15.19%, and 14.96% respectively.

Portfolio Pulse from Benzinga Insights

October 24, 2023 | 5:31 pm

During Friday's pre-market session, several health care stocks experienced significant movement. Lipella Pharmaceuticals, Aravive, American Well, Akso Health Group, Comera Life Sciences, and 180 Life Sciences saw increases in their stock prices, while Processa Pharma, Arcutis Biotherapeutics, SeaStar Medical Holding, Biocept, Atreca, and Meihua Intl Medical Techs experienced decreases.

Portfolio Pulse from Benzinga Insights

October 20, 2023 | 1:06 pm

Several healthcare stocks experienced significant movement in Thursday's after-market session. Notable gainers included American Well (AMWL), Comera Life Sciences (CMRA), Generation Bio (GBIO), Applied Molecular (AMTI), HOOKIPA Pharma (HOOK), and GRI Bio (GRI). On the other hand, Atreca (BCEL), Processa Pharma (PCSA), Ontrak (OTRKP), Bio-Path Hldgs (BPTH), Arcutis Biotherapeutics (ARQT), and Intuitive Surgical (ISRG) saw their stock prices fall.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 9:31 pm

Several stocks are experiencing significant pre-market movements. Biocept, Inc. (BIOC) surged 91.8% after filing for Chapter 7 bankruptcy. Shift Technologies, Inc. (SFT) rose 74.4% after announcing plans to file for Chapter 11 bankruptcy. Connexa Sports Technologies Inc. (CNXA) gained 45% and RVL Pharmaceuticals plc (RVLP) climbed 41.2% after receiving a delisting notice. Talaris Therapeutics, Inc. (TALS) jumped 8.2% after announcing stockholder approval of a merger with Tourmaline Bio and a 1-for-10 reverse stock split.

Portfolio Pulse from Lisa Levin

October 18, 2023 | 12:19 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. Bio-Path Hldgs, Processa Pharma, Harpoon Therapeutics, SELLAS Life Sciences Gr, Agape ATP, and Assure Hldgs saw their stocks rise, with Bio-Path Hldgs leading the gainers with a 60.6% increase. On the other hand, Bellerophon Therapeutics, Outset Medical, Harmony Biosciences, Comera Life Sciences, Catalyst Biosciences, and PMV Pharma saw their stocks decline, with Bellerophon Therapeutics leading the losers with a 64.9% decrease.

Portfolio Pulse from Benzinga Insights

October 13, 2023 | 5:31 pm

Several healthcare stocks experienced significant movement in Thursday's after-market session. Bio-Path Hldgs, Comera Life Sciences, Scinai Immunotherapeutics, 60 Degrees, Bellerophon Therapeutics, and Relay Therapeutics saw increases, while Cassava Sciences, Outset Medical, T2 Biosystems, OpGen, Tempest Therapeutics, and BeyondSpring saw decreases.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 9:32 pm

In Thursday's pre-market session, several health care stocks experienced significant movement. Dyadic International, MAIA Biotechnology, KORU Medical Systems, Comera Life Sciences, Nuwellis, and Xilio Therapeutics saw increases in their share prices, while MaxCyte, SeaStar Medical Holding, Owlet, Nanobiotix, Innate Pharma, and Neoleukin Therapeutics experienced decreases.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 1:10 pm

During Friday's after-market session, several health care stocks experienced significant movement. Bionomics (BNOX), Oragenics (OGEN), and Syndax Pharmaceuticals (SNDX) were among the gainers, with increases of 24.0%, 21.54%, and 15.15% respectively. On the other hand, Comera Life Sciences (CMRA), TC BioPharm (TCBP), and NeuBase Therapeutics (NBSE) were among the losers, with decreases of 12.3%, 6.98%, and 5.73% respectively.

Portfolio Pulse from Benzinga Insights

September 29, 2023 | 9:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.